Philosophy:Treatment of mental disorders
|Treatment of mental disorders|
|Specialty||psychiatry and clinical psychology|
Mental disorders are classified as a psychological condition marked primarily by sufficient disorganization of personality, mind, and emotions to seriously impair the normal psychological and often social functioning of the individual. Individuals diagnosed with certain mental disorders can be unable to function normally in society. Mental disorders may consist of several affective, behavioral, cognitive and perceptual components. The acknowledgement and understanding of mental health conditions has changed over time and across cultures. There are still variations in the definition, classification, and treatment of mental disorders.
Treatments, as well as societies attitudes towards mental illnesses have substantially changed throughout the years. Many earlier treatments for mental illness were later deemed as ineffective as well dangerous; but though years of research, studies, and medical developments, many current treatments are now effective and safe for patients. Early glimpses of treatment of mental illness included dunking in cold water by Samuel Willard (physician), who reportedly established the first American hospital for mental illness. The history of treatment of mental disorders consists in a development through years mainly in both psychotherapy (Cognitive therapy, Behavior therapy, Group Therapy, and ECT) and psychopharmacology (drugs used in mental disorders).
Different perspectives on the causes of psychological disorders arose. Some believed that stated that psychological disorders are caused by specific abnormalities of the brain and nervous system and that is, in principle, they should be approached for treatments in the same way as physical illness (arose from Hippocrates's ideas).
Psychotherapy is a relatively new method used in treatment of mental disorders. The practice of individual psychotherapy as a treatment of mental disorders is about 100 years old. Sigmund Freud (1856–1939) was the first one to introduce this concept in psychoanalysis. Cognitive behavioral therapy is a more recent therapy that was founded in the 1960s by Aaron T. Beck, an American psychiatrist. It is a more systematic and structured part of psychotherapy. It consist in helping the patient learn effective ways to overcome their problems and difficulties that causes them distress. Behavior therapy has its roots in experimental psychology. E.L. Thorndike and B.F. Skinner were among the first to work on behavior therapy.
Convulsive therapy was introduced by Ladislas Meduna in 1934. He induced seizures through a series of injections, as a means to attempt to treat schizophrenia. Meanwhile, in Italy, Ugo Cerletti substituted injections with electricity. Because of this substitution the new theory was called electroconvulsive therapy (ECT).
Beside psychotherapy, a wide range of medication is used in the treatment of mental disorders. The first drugs used for this purpose were extracted from plants with psychoactive properties. Louis Lewin, in 1924, was the first one to introduce a classification of drugs and plants that had properties of this kind. The history of the medications used in mental disorders has developed a lot through years. The discovery of modern drugs prevailed during the 20th century. Lithium, a mood stabilizer, was discovered as a treatment of mania, by John F. Cade in 1949, "and Hammond (1871) used lithium bromide for 'acute mania with depression'". In 1937, Daniel Bovet and Anne-Marie Staub discovered the first antihistamine. In 1951 Paul Charpentier synthesized chlorpromazine an antipsychotic.
There are numbers of practitioners who have influenced the treatment of modern mental disorders. One of the most important among them was Benjamin Rush. Benjamin Rush (1746–1813) was considered the Father of American Psychiatry for his many works and studies in the mental health field. He tried to classify different types of mental disorders, he theorized about their causes, and tried to find possible cures for them. Rush believed that mental disorders were caused by poor blood circulation, though he was wrong. He also described Savant Syndrome and had an approach to addictions.
Other important early psychiatrists include George Parkman, Oliver Wendell Holmes Sr., George Zeller, Carl Jung, Leo Kanner, and Peter Breggin. George Parkman (1790–1849) got his medical degree at the University of Aberdeen in Scotland. He was influenced by Benjamin Rush, who inspired him to take interest in the state asylums. He trained at the Parisian Asylum. Parkman wrote several papers on treatment for the mentally ill. Oliver Wendell Holmes Sr.(1809–1894) was an American Physician who wrote many famous writings on medical treatments. George Zeller (1858–1938) was famous for his way of treating the mentally ill. He believed they should be treated like people and did so in a caring manner. He banned narcotics, mechanical restraints, and imprisonment while he was in charge at Peoria State Asylum. Peter Breggin (1939–present) disagrees with the practices of harsh psychiatry such as electroconvulsive therapy. 
A form of treatment for many mental disorders is Psychotherapy. Psychotherapy is an interpersonal intervention, usually provided by a mental health professional such as a clinical psychologist, that employs any of a range of specific psychological techniques. There are several main types. Cognitive behavioral therapy (CBT) is used for a wide variety of disorders, based on modifying the patterns of thought and behavior associated with a particular disorder. There are various kinds of CBT therapy, and offshoots such as dialectical behavior therapy. Psychoanalysis, addressing underlying psychic conflicts and defenses, has been a dominant school of psychotherapy and is still in use. Systemic therapy or family therapy is sometimes used, addressing a network of relationships as well as individuals themselves. Some psychotherapies are based on a humanistic approach. Some therapies are for a specific disorder only, for example interpersonal and social rhythm therapy. Mental health professionals often pick and choose techniques, employing an eclectic or integrative approach tailored to a particular disorder and individual. Much may depend on the therapeutic relationship, and there may be issues of trust, confidentiality and engagement.
To regulate the potentially powerful influences of therapies, psychologists hold themselves to a set of ethical standers for the treatment of people with mental disorders, written by the American Psychological Association. These ethical standards include:
- Striving to benefit clients and taking care to do no harm;
- Establishing relationships of trust with clients;
- Promoting accuracy, honesty, and truthfulness;
- Seeking fairness in treatment and taking precautions to avoid biases;
- Respecting the dignity and worth of all people.
Psychiatric medication is also widely used to treat mental disorders. These are licensed psychoactive drugs usually prescribed by a psychiatrist or family doctor. There are several main groups. Antidepressants are used for the treatment of clinical depression as well as often for anxiety and other disorders. Anxiolytics are used, generally short-term, for anxiety disorders and related problems such as physical symptoms and insomnia. Mood stabilizers are used primarily in bipolar disorder, mainly targeting mania rather than depression. Antipsychotics are used for psychotic disorders, notably in schizophrenia. However, they are also often used to treat bipolar disorder in smaller doses to treat anxiety. Stimulants are commonly used, notably for ADHD.
Despite the different conventional names of the drug groups, there can be considerable overlap in the kinds of disorders for which they are actually indicated. There may also be off-label use. There can be problems with adverse effects and adherence.
In addition of atypical antipsychotics in cases of inadequate response to antidepressant therapy is an increasingly popular strategy that is well supported in the literature, though these medications may result in greater discontinuation due to adverse events. Aripiprazole was the first drug approved by the US Food and Drug Administration for adjunctive treatment of MDD in adults with inadequate response to antidepressant therapy in the current episode. Recommended doses of aripiprazole range from 2 mg/d to 15 mg/d based on 2 large, multicenter randomized, double-blind, placebo-controlled studies, which were later supported by a third large trial. Most conventional antipsychotics, such as the phenothiazines, work by blocking the D2 Dopamine receptors. Atypical antipsychotics, such as clozapine block both the D2 Dopamine receptors as well as 5HT2A serotonin receptors. Atypical antipsychotics are favored over conventional antipsychotics because they reduce the prevalence of pseudoparkinsonism which causes tremors and muscular rigidity similar to Parkinson’s disease. The most severe side effect of antipsychotics is agranulocytosis, a depression of white blood cell count with unknown cause, and some patients may also experience photosensitivity.
Early antidepressants were discovered through research on treating tuberculosis and yielded the class of antidepressants known as monoamine oxidase inhibitors (MAO). Only two MAO inhibitors remain on the market in the United States because they alter the metabolism of the dietary amino acid tyramine which can lead to a hypertensive crisis. Research on improving phenothiazine antipsychotics led to the development of tricyclic antidepressants which inhibit synaptic uptake of the neurotransmitters norepinephrine and serotonin. SSRIs or selective serotonin reuptake inhibitors are the most frequently used antidepressant. These drugs share many similarities with the tricyclic antidepressants but are more selective in their action. The greatest risk of the SSRIs is an increase in violent and suicidal behavior, particularly in children and adolescents. In 2006 antidepressant sales worldwide totaled $15 billion USD and over 226 million prescriptions were given.
Research on the effects of physical activity on mental illness
As increasing evidence of the benefits of physical activity has become apparent, research on the mental benefits of physical activity has been examined. While it was originally believed that physical activity only slightly benefits mood and mental state, overtime positive mental effects from physical activity became more pronounced. Scientists began completing studies, which were often highly problematic due to problems such as getting patients to complete their trials, controlling for all possible variables, and finding adequate ways to test progress. Data were often collected through case and population studies, allowing for less control, but still gathering observations. More recently studies have begun to have more established methods in an attempt to start to comprehend the benefits of different levels and amounts of fitness across multiple age groups, genders, and mental illnesses. Some psychologists are recommending fitness to patients, however the majority of doctors are not prescribing patients with a full program.
Many early studies show that physical activity has positive effects on subjects with mental illness. Most studies have shown that higher levels of exercise correlate to improvement in mental state, especially for depression. On the other hand, some studies have found that exercise can have a beneficial short-term effect at lower intensities. Demonstrating that lower intensity sessions with longer rest periods produced significantly higher positive affect and reduced anxiety when measured shortly after. Physical activity was found to be beneficial regardless of age and gender. Some studies found exercise to be more effective at treating depression than medication over long periods of time, but the most effective treatment of depression was exercise in combination with antidepressants. Exercise appeared to have the greatest effect on mental health a short period of time after exercise. Different studies have found this time to be from twenty minutes to several hours. Patients who have added exercise to other treatments tend to have more consistent long lasting relief from symptoms than those who just take medication. No single regimented workout has been agreed upon as most effective for any mental illness at this time. The exercise programs prescribed are mostly intended to get patients doing some form of physical activity, as the benefits of doing any form of exercise have been proven to be better than doing nothing at all.
Electroconvulsive therapy (known as ECT) is when electric currents are applied to someone with a mental disorder who is not responding well to other forms of therapy. Psychosurgery, including deep brain stimulation, is another available treatment for some disorders. This form of therapy is disputed in many cases on its ethicality and effectiveness.
Creative therapies are sometimes used, including music therapy, art therapy or drama therapy. Each form of these therapy involves performing, creating, listening to, observing, or being a part of the therapeutic act.
Lifestyle adjustments and supportive measures are often used, including peer support, self-help and supported housing or employment. Some advocate dietary supplements. A placebo effect may play a role.
Mental health services may be based in hospitals, clinics or the community. Often an individual may engage in different treatment modalities and use various mental health services. These may be under case management (sometimes referred to as "service coordination"), use inpatient or day treatment. Patients can utilize a psychosocial rehabilitation program or take part in an assertive community treatment program. Providing optimal treatments earlier in the course of a mental health disorder may prevent further relapses and ongoing disability. This has led to a new early intervention in psychosis service approach for psychosis Some approaches are based on a recovery model of mental disorder, and may focus on challenging stigma and social exclusion and creating empowerment and hope.
In America, half of people with severe symptoms of a mental health condition were found to have received no treatment in the prior 12 months. Fear of disclosure, rejection by friends, and ultimately discrimination are a few reasons why people with mental health conditions often don't seek help.
Stigmas and treatment
Stigma against mental disorders can lead people with mental health conditions not to seek help. Two types of mental health stigmas include social stigma and perceived stigma. Though separated into different categories, the two can interact with each other, where prejudicial attitudes in social stigma lead to the internalization of discriminatory perceptions in perceived stigma.
The stigmatization of mental illnesses can elicit stereotypes, some common ones including violence, incompetence, and blame. However, the manifestation of that stereotype into prejudice may not always occur. When it does, prejudice leads to discrimination, the behavioral reaction.
Public stigmas may also harm social opportunities. Prejudice frequently disallows people with mental illnesses from finding suitable housing or procuring good jobs. Studies have shown that stereotypes and prejudice about mental illness have harmful impacts on obtaining and keeping good jobs. This, along with other negative effects of stigmatization have led researchers to conduct studies on the relationship between public stigma and care seeking. Researchers have found that an inverse relationship exists between public stigma and care seeking, as well as between stigmatizing attitudes and treatment adherence. Furthermore, specific beliefs that may influence people not to seek treatment have been identified, one of which is concern over what others might think.
The internalization of stigmas may lead to self-prejudice which in turn can lead a person to experience negative emotional reactions, interfering with a person's quality of life. Research has shown a significant relationship between shame and avoiding treatment. A study measuring this relationship found that research participants who expressed shame from personal experiences with mental illnesses were less likely to participate in treatment. Additionally, family shame is also a predictor of avoiding treatment. Research showed that people with psychiatric diagnoses were more likely to avoid services if they believed family members would have a negative reaction to said services. Hence, public stigma can influence self-stigma, which has been shown to decrease treatment involvement. As such, the interaction between the two constructs impact care seeking.
List of treatments
- Somatotherapy (type of pharmacotherapy; biology-based treatments)
- Psychiatric medications (psychoactive drugs used in psychiatry)
- Antianxiety drugs (anxiolytics)
- Antidepressant drugs
- Antipsychotic drugs
- Mood stabilizers
- Shock therapy also known as convulsive therapies
- Leukotomy (prefrontal lobotomy; no longer practiced)
- Bilateral cingulotomy
- Deep brain stimulation
- Psychiatric medications (psychoactive drugs used in psychiatry)
- Psychotherapy (psychology-based treatment)
- Lincoln, William (1862). "History of Worcester, Mass. from its Earliest settlement to 1836" by Charles Hersey. Worcester, Mass.: Hersey/Henry Howland Press. https://books.google.com/?id=8MRCObZ79wEC&pg=PA222&lpg=PA222&dq=dr+samuel+willard+of+uxbridge+born+died.
- "Archived copy". http://dlib.cwmars.org/cdm4/item_viewer.php?CISOROOT=%2Fuxbridge&CISOPTR=48. Digital Treasures, Samuel Willard ran a "hospital for the insane" l and trained young physicians, East side of Uxbridge Common, (no longer standing)
- 1947-, Meyer, Jerrold S. (2005). Psychopharmacology : drugs, the brain, and behavior. Quenzer, Linda F.. Sunderland, Mass.: Sinauer Associates, Publishers. ISBN 978-0878935345. OCLC 57254391.
- R. Carlson, Neil (2010). Psychology the Science of Behaviour. Toronto, Ontario: Pearson Education Incorporated. pp. 548–549. ISBN 978-0-205-64524-4. https://archive.org/details/psychologyscienc0004unse/page/548.
- Mulhauser, Greg. "History of Counselling & Psychotherapy". http://counsellingresource.com/therapy/types/history/.
- "Our History | Beck Institute of Cognitive Behavior Therapy". Beck Institute for Cognitive Behavior Therapy. https://www.beckinstitute.org/about-beck/our-history/.
- "What is Cognitive Behavior Therapy | Beck Institute". Beck Institute for Cognitive Behavior Therapy. https://www.beckinstitute.org/get-informed/what-is-cognitive-therapy/.
- (in en) Behavior Therapy. Ardent Media. 1969. https://books.google.com/?id=qLvpIt-eCsQC&pg=PA73&dq=studies+in+behavior+therapy+skinner#v=onepage&q=skinner&f=false.
- "Edward Thorndike - Law of Effect | Simply Psychology". https://www.simplypsychology.org/edward-thorndike.html.
- "Meduna, Ladislas J. - Dictionary definition of Meduna, Ladislas J. | Encyclopedia.com: FREE online dictionary" (in en). http://www.encyclopedia.com/history/encyclopedias-almanacs-transcripts-and-maps/meduna-ladislas-j.
- Endler, Norman (1988). "The Origins of Electroconvulsive Therapy (ECT)". Convulsive Therapy 4 (1): 5–23. PMID 11940939. http://breggin.com/wp-content/uploads/2008/03/TheOriginsECTNEndler1988.pdf.
- House, Via the (2011-03-11). "Phantastica by Louis Lewin". http://psypressuk.com/2011/03/11/literary-review-phantastica-by-louis-lewin/.
- Schou, M. (1 August 1992). "The first psychiatric use of lithium.". The British Journal of Psychiatry 161 (2): 279–280. doi:10.1192/bjp.161.2.279. PMID 1482477.
- Church, Diana S.; Church, Martin K. (2011-12-01). "Pharmacology of Antihistamines". World Allergy Organization Journal 4: S22–S27. doi:10.1186/1939-4551-4-S3-S22. ISSN 1939-4551. PMID 23282332.
- Ban, Thomas A (August 2007). "Fifty years chlorpromazine: a historical perspective". Neuropsychiatric Disease and Treatment 3 (4): 495–500. ISSN 1176-6328. PMID 19300578.
- "Diseases of the Mind: Highlights of American Psychiatry through 1900 - Benjamin Rush". https://www.nlm.nih.gov/hmd/diseases/benjamin.html.
- "Savant syndrome facts, information, pictures | Encyclopedia.com articles about Savant syndrome" (in en). http://www.encyclopedia.com/medicine/psychology/psychology-and-psychiatry/savant-syndrome.
- Hanson, Dirk (2010-07-05). "Addiction Inbox: Dr. Benjamin Rush and "Diseases of the Mind"". http://addiction-dirkh.blogspot.com/2010/07/dr-benjamin-rush-and-diseases-of-mind.html.
- Holmes, Oliver Wendell (1850). The benefactors of the Medical School of Harvard University : with a biographical sketch of the late Dr. George Parkman : an introductory lecture, delivered at the Massachusetts Medical College, November 7, 1850. U. S. National Library of Medicine. Boston : Ticknor, Reed, and Fields. https://archive.org/details/56030050R.nlm.nih.gov.
- "Oliver Wendell Holmes - Biography and Works. Search Texts, Read Online. Discuss." (in en). http://www.online-literature.com/oliver-holmes/.
- POLLAK, MAXIM; BAER, WALTER H. (1953). "The Friend of the Bereft George Anthony Zeller, M. D. 1858-1938". Journal of the History of Medicine and Allied Sciences 8 (1): 56–69. doi:10.1093/jhmas/viii.january.56. PMID 13011302.
- Breggin, Peter (1979). Electro-Shock Its Brain-Disabling Effects. New York City: Springer Publishing Company. ISBN 978-0826127105.
- "What is Psychotherapy?". https://www.psychiatry.org/patients-families/psychotherapy.
- "Understanding psychotherapy and how it works". http://www.apa.org/helpcenter/understanding-psychotherapy.aspx.
- Schacter, D. L., Gilbert, D. T., & Wegner, D. M. (2010). Psychology. (2nd ed., p. 620). New York: Worth Pub.
- "What Medications Help to Treat Depression?" (in en). Healthline. http://www.healthline.com/health/depression/medication-list#ssris2.
- "List of Anxiolytics, sedatives, and hypnotics - Drugs.com" (in en-US). Drugs.com. https://www.drugs.com/drug-class/anxiolytics-sedatives-and-hypnotics.html.
- "Medication for Bipolar Disorder" (in en-US). WebMD. http://www.webmd.com/bipolar-disorder/guide/medications-bipolar-disorder#1.
- "Maintenance therapy with second generation antipsychotics for bipolar disorder – A systematic review and meta-analysis" (in en). Journal of Affective Disorders 213: 138–150. 2017-04-15. doi:10.1016/j.jad.2017.02.012. ISSN 0165-0327. https://www.sciencedirect.com/science/article/abs/pii/S0165032716316251.
- "List of Antipsychotics - Drugs.com" (in en-US). Drugs.com. https://www.drugs.com/drug-class/antipsychotics.html.
- Abuse, National Institute on Drug. "Stimulant ADHD Medications: Methylphenidate and Amphetamines" (in en-US). https://www.drugabuse.gov/publications/drugfacts/stimulant-adhd-medications-methylphenidate-amphetamines.
- "Medication". Mental Health America. 2013-10-31. http://www.mentalhealthamerica.net/medication.
- David Mischoulon; Janet Witte; Michael Levy; George I. Papakostas; L. Russell Pet; Wen-hua Hsieh; Michael J. Pencina; Sean Ward et al. (2011-10-02). "Efficacy of Dose Increase Among Nonresponders to Low-Dose Aripiprazole Augmentation in Patients With Inadequate Response to Antidepressant Treatment: A Randomized, Double-Blind, Placebo-Controlled, Efficacy Trial". Journal of Clinical Psychology 73 (3): 353–357. doi:10.4088/JCP.10m06541. PMID 21939613. http://www.psychiatrist.com/privatepdf/article_wrapper.asp?art=oap/10m06541/10m06541.htm. Retrieved 2011-10-10. Subscription required.
- "Antipsychotic Medications | Psych Central" (in en-US). Psych Central. 2016-05-17. https://psychcentral.com/lib/antipsychotic-medications/.
- "Antipsychotics. Drugs - how do they work? Medicine info" (in en-GB). https://patient.info/health/antipsychotic-medicines.
- "Monoamine oxidase inhibitors (MAOIs)" (in en). Mayo Clinic. http://www.mayoclinic.org/diseases-conditions/depression/in-depth/maois/art-20043992.
- "Tricyclic antidepressants (TCAs)" (in en). Mayo Clinic. http://www.mayoclinic.org/diseases-conditions/depression/in-depth/antidepressants/art-20046983.
- "What Are SSRIs?" (in en-US). WebMD. http://www.webmd.com/depression/ssris-myths-and-facts-about-antidepressants#1.
- Mark, Tami L.; Kassed, Cheryl A.; Vandivort-Warren, Rita; Levit, Katharine R.; Kranzler, Henry R. (2009-01-01). "Alcohol and Opioid Dependence Medications: Prescription Trends, Overall and by Physician Specialty". Drug and Alcohol Dependence 99 (1–3): 345–349. doi:10.1016/j.drugalcdep.2008.07.018. ISSN 0376-8716. PMID 18819759.
- Martinsen, Egil W. (2008-01-01). "Physical activity in the prevention and treatment of anxiety and depression". Nordic Journal of Psychiatry 62 (sup47): 25–29. doi:10.1080/08039480802315640. ISSN 0803-9488. PMID 18752115.
- Landers, Daniel M.; Arent, Shawn M. (2007). Tenenbaum, Gershon. ed (in en). Handbook of Sport Psychology. John Wiley & Sons, Inc.. pp. 467–491. doi:10.1002/9781118270011.ch21. ISBN 9781118270011. https://archive.org/details/handbooksportpsy00tene.
- De Moor, M. H. M.; Beem, A. L.; Stubbe, J. H.; Boomsma, D. I.; De Geus, E. J. C. (April 2006). "Regular exercise, anxiety, depression and personality: a population-based study". Preventive Medicine 42 (4): 273–279. doi:10.1016/j.ypmed.2005.12.002. ISSN 0091-7435. PMID 16439008. http://www.tweelingenregister.org/nederlands/verslaggeving/NTR_publicaties_2006/Moor_PM_2006.pdf.
- Reynolds, Gretchen (2016-11-16). "How Exercise Might Keep Depression at Bay" (in en-US). The New York Times. ISSN 0362-4331. https://www.nytimes.com/2016/11/16/well/move/how-exercise-might-keep-depression-at-bay.html.
- Dunn, Andrea L.; Trivedi, Madhukar H.; Kampert, James B.; Clark, Camillia G.; Chambliss, Heather O. (2005-01-01). "Exercise treatment for depression". American Journal of Preventive Medicine 28 (1): 1–8. doi:10.1016/j.amepre.2004.09.003. PMID 15626549.
- Nabkasorn, Chanudda; Miyai, Nobuyuki; Sootmongkol, Anek; Junprasert, Suwanna; Yamamoto, Hiroichi; Arita, Mikio; Miyashita, Kazuhisa (April 2006). "Effects of physical exercise on depression, neuroendocrine stress hormones and physiological fitness in adolescent females with depressive symptoms". European Journal of Public Health 16 (2): 179–184. doi:10.1093/eurpub/cki159. ISSN 1101-1262. PMID 16126743.
- Sidhu, Kanwaldeep; Vandana, Pankhuree; Balon, Richard (June 2009). "Exercise prescription: A practical, effective therapy for depression". Current Psychiatry 8 (6): 39–51. http://www.mdedge.com/currentpsychiatry/article/63598/exercise-prescription-practical-effective-therapy-depression.
- Bibeau, Wendy S.; Moore, Justin B.; Mitchell, Nathanael G.; Vargas-Tonsing, Tiffanye; Bartholomew, John B. (August 2010). "Effects of acute resistance training of different intensities and rest periods on anxiety and affect". Journal of Strength and Conditioning Research 24 (8): 2184–2191. doi:10.1519/JSC.0b013e3181ae794b. ISSN 1533-4287. PMID 19834350.
- "Brain Stimulation Therapies". https://www.nimh.nih.gov/health/topics/brain-stimulation-therapies/brain-stimulation-therapies.shtml.
- Sedrak, M.; Wong, W.; Wilson, P.; Bruce, D.; Bernstein, I.; Khandhar, S.; Pappas, C.; Heit, G. et al. (2013). "Deep Brain Stimulation for the Treatment of Severe, Medically Refractory Obsessive-Compulsive Disorder". The Permanente Journal 17 (4): 47–51. doi:10.7812/TPP/13-005. PMID 24361021.
- Nakul Talwar; Mike J. Crawford; Anna Maratos; Ula Nur; Orii Mcdermott; Simon Procter (2006). "Music therapy for in-patients with schizophrenia: Exploratory randomised controlled trial". The British Journal of Psychiatry 189 (5): 405–9. doi:10.1192/bjp.bp.105.015073. PMID 17077429. "Music therapy may provide a means of improving mental health among people with schizophrenia, but its effects in acute psychoses have not been explored".
- "What is Art Therapy? | What Does an Art Therapist Do?" (in en-US). Art Therapy. http://www.arttherapyblog.com/what-is-art-therapy/#.WYlQz62ZORs.
- "What is Drama Therapy". http://www.nadta.org/what-is-drama-therapy.html.
- "Depression Treatment: Therapy, Medication, and Lifestyle Changes That Can Help" (in en). https://www.helpguide.org/articles/depression/depression-treatment.htm.
- "Alternative Treatments for Depression" (in en-US). WebMD. http://www.webmd.com/depression/guide/alternative-therapies-depression#1.
- "The Placebo Effect: What Is It?" (in en-US). WebMD. http://www.webmd.com/pain-management/what-is-the-placebo-effect#1.
- Repper, J. & Perkins, R. (2006) Social Inclusion and Recovery: A Model for Mental Health Practice. Bailliere Tindall, UK. ISBN:0-7020-2601-8
- America's Mental Health Survey, National Mental Health Association, 2001.
- Corrigan, Patrick (2004). "How Stigma Interferes With Mental Health Care". American Psychologist 59 (7): 614–625. doi:10.1037/0003-066X.59.7.614. PMID 15491256.
- "Payment by Results: mental health payments for 2013 to 2014 - GOV.UK". https://www.gov.uk/government/publications/mental-health-payment-by-results-arrangements-for-2013-14.
- "A quick guide to mental health payment by results and its impact on social work". 16 April 2013. http://www.communitycare.co.uk/2013/04/16/a-quick-guide-to-mental-health-payment-by-results-and-its-impact-on-social-work/.
- Crocker, J., Major, B., & Steele, C. (1998). Social stigma. In D. T. Gilbert, S. Fiske, & G. Lindzey (Eds.), The handbook of social psychology (Vol. 2, 4th ed., pp. 504–553). New York: McGraw-Hill.
- Bordieri J. E., Drehmer D. E. (1986). "Hiring decisions for disabled workers: Looking at the cause". Journal of Applied Social Psychology 16: 197–208. doi:10.1111/j.1559-1816.1986.tb01135.x.
- Cooper A., Corrigan P. W., Watson A. C. (2003). "Mental illness stigma and care seeking". Journal of Nervous and Mental Disease 191: 339–341. doi:10.1097/01.nmd.0000066157.47101.22.
- Sirey J. A., Bruce M. L., Alexopoulos G. S., Perlick D. A., Raue P., Friedman S. J., Meyers B. S. (2001). "Perceived stigma as a predictor of treatment discontinuation in young and older outpatients with depression". American Journal of Psychiatry 158: 479–481. doi:10.1176/appi.ajp.158.3.479.
- Kessler R. C., Berglund P. A., Bruce M. L., Koch R., Laska E. M., Leaf P. J. (2001). "The prevalence and correlates of untreated serious mental illness". Health Services Research 36: 987–1007.
- Leaf P. J., Bruce M. L., Tischler G. L. (1986). "The differential effect of attitudes on the use of mental health services". Social Psychiatry 21: 187–192. doi:10.1007/bf00583999.
- Mind, Brain, and Personality Disorders Am. J. Psychiatry 1 April 2005: 648-655.
- General Psychiatry JAMA 16 September 1998: 961-962
- The practice of medicinal chemistry, Camille Georges Wermuth
- Theories of Psychotherapy & Counseling: Concepts and Cases, Richard S. Sharf
- Cognitive behavioural interventions in physiotherapy and occupational therapy, Marie Donaghy, Maggie Nicol, Kate M. Davidson
- Key concepts in psychotherapy integration, Jerold R. Gold
- , Wikidata Q19094087